1,016 filings
Page 27 of 51
8-K
ABIO
ARCA biopharma Inc
6 Aug 13
Entry into a Material Definitive Agreement
12:00am
424B4
ABIO
ARCA biopharma Inc
6 Aug 13
Prospectus supplement with pricing info
12:00am
DEFA14A
ABIO
ARCA biopharma Inc
1 Aug 13
Additional proxy soliciting materials
12:00am
DEF 14A
ABIO
ARCA biopharma Inc
Definitive proxy
1 Aug 13
12:00am
424B4
ABIO
ARCA biopharma Inc
31 Jul 13
Prospectus supplement with pricing info
12:00am
8-K
ABIO
ARCA biopharma Inc
30 Jul 13
Raymond L. Woosley, M.D., PH.D. Appointed to Arca Biopharma Board of Directors
12:00am
424B4
ABIO
ARCA biopharma Inc
25 Jul 13
Prospectus supplement with pricing info
12:00am
8-K
ABIO
ARCA biopharma Inc
25 Jul 13
ARCA biopharma Announces Additions to GENETIC-AF Leadership Team
12:00am
424B4
ABIO
ARCA biopharma Inc
19 Jul 13
Prospectus supplement with pricing info
12:00am
8-K
ABIO
ARCA biopharma Inc
18 Jul 13
Arca Biopharma Provides Business Update
12:00am
424B4
ABIO
ARCA biopharma Inc
18 Jul 13
Prospectus supplement with pricing info
12:00am
CT ORDER
ABIO
ARCA biopharma Inc
16 Jul 13
Confidential treatment order
12:00am
8-K
ABIO
ARCA biopharma Inc
1 Jul 13
Regulation FD Disclosure
12:00am
8-K
ABIO
ARCA biopharma Inc
18 Jun 13
Departure of Directors or Certain Officers
12:00am
D
ABIO
ARCA biopharma Inc
17 Jun 13
$1.25M in options / securities to be acquired, sold $1.25M, 2 investors
12:00am
SC 13G/A
ABIO
ARCA biopharma Inc
14 Jun 13
ARCA biopharma, Inc.
12:00am
8-K
ABIO
ARCA biopharma Inc
6 Jun 13
Pharmacogenetic Enhancement of Effectiveness for Prevention of Atrial
12:00am
SC 13G
ABIO
ARCA biopharma Inc
3 Jun 13
ARCA biopharma, Inc.
12:00am
8-K
ABIO
ARCA biopharma Inc
30 May 13
Arca Biopharma Announces Pricing of $20 Million Equity Offering
12:00am
424B4
ABIO
ARCA biopharma Inc
30 May 13
Prospectus supplement with pricing info
12:00am